<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:13:53Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6105042" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6105042</identifier>
        <datestamp>2018-08-23</datestamp>
        <setSpec>neurology</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Neurology</journal-id>
              <journal-id journal-id-type="iso-abbrev">Neurology</journal-id>
              <journal-id journal-id-type="hwp">neurology</journal-id>
              <journal-id journal-id-type="publisher-id">neur</journal-id>
              <journal-id journal-id-type="publisher-id">NEUROLOGY</journal-id>
              <journal-title-group>
                <journal-title>Neurology</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0028-3878</issn>
              <issn pub-type="epub">1526-632X</issn>
              <publisher>
                <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
                <publisher-loc>Hagerstown, MD</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6105042</article-id>
              <article-id pub-id-type="pmcid">PMC6105042</article-id>
              <article-id pub-id-type="pmc-uid">6105042</article-id>
              <article-id pub-id-type="pmid">30006412</article-id>
              <article-id pub-id-type="pmid">30006412</article-id>
              <article-id pub-id-type="publisher-id">NEUROLOGY2017863324</article-id>
              <article-id pub-id-type="doi">10.1212/WNL.0000000000005994</article-id>
              <article-categories>
                <subj-group subj-group-type="hwp-journal-coll">
                  <subject>1</subject>
                  <subject>316</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Newton</surname>
                    <given-names>Julia L.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <author-comment content-type="disclosure">
                    <p>
                      <list list-type="order">
                        <title>Scientific Advisory Boards:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Gifts:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Funding for Travel or Speaker Honoraria:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Editorial Boards:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Patents:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Publishing Royalties:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Employment, Commercial Entity:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Consultancies:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Speakers' Bureaus:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Other Activities:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Clinical Procedures or Imaging Studies:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Research Support, Commercial Entities:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Research Support, Government Entities:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Research Support, Academic Entities:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Research Support, Foundations and Societies:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Stock/Stock Options/Board of Directors Compensation:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>License Fee Payments, Technology or Inventions:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Royalty Payments, Technology or Inventions:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Stock/Stock Options, Research Sponsor:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Legal Proceedings:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                  </author-comment>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Frith</surname>
                    <given-names>James</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <author-comment content-type="disclosure">
                    <p>
                      <list list-type="order">
                        <title>Scientific Advisory Boards:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Gifts:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Funding for Travel or Speaker Honoraria:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Editorial Boards:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Patents:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Publishing Royalties:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Employment, Commercial Entity:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Consultancies:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Speakers' Bureaus:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Other Activities:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Clinical Procedures or Imaging Studies:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Research Support, Commercial Entities:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Research Support, Government Entities:</title>
                        <list-item>
                          <p>1. UK National Institute for Health Research Clinician Scientist Fellowship (CS-2014-002), 2015-2020 This report is independent research arising from an NIHR Clinician Scientist award (CS-2014-002) supported by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the UK NHS, the NIHR or the Department of Health.</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Research Support, Academic Entities:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Research Support, Foundations and Societies:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Stock/Stock Options/Board of Directors Compensation:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>License Fee Payments, Technology or Inventions:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Royalty Payments, Technology or Inventions:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Stock/Stock Options, Research Sponsor:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                    <p>
                      <list list-type="order">
                        <title>Legal Proceedings:</title>
                        <list-item>
                          <p>NONE</p>
                        </list-item>
                      </list>
                    </p>
                  </author-comment>
                </contrib>
                <aff>From the Institute of Cellular Medicine (J.L.N.), Newcastle University; Falls and Syncope Service (J.L.N., J.F.), Newcastle Upon Tyne Hospitals NHS Foundation Trust; and NIHR Newcastle Biomedical Research Centre (J.F.), Newcastle Upon Tyne Hospitals NHS Trust and Newcastle University, UK.</aff>
              </contrib-group>
              <author-notes>
                <corresp><bold>Correspondence</bold> Dr. Frith <email>james.frith@newcastle.ac.uk</email></corresp>
                <fn fn-type="financial-disclosure">
                  <p>Go to <ext-link xlink:href="http://n.neurology.org/lookup/doi/10.1212/WNL.0000000000005994" ext-link-type="uri">Neurology.org/N</ext-link> for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.</p>
                </fn>
                <fn fn-type="other">
                  <p>The Article Processing Charge was funded by UK National Institute for Health Research.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="ppub">
                <day>14</day>
                <month>8</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>14</day>
                <month>8</month>
                <year>2018</year>
              </pub-date>
              <!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="ppub"/>.-->
              <volume>91</volume>
              <issue>7</issue>
              <fpage>e652</fpage>
              <lpage>e656</lpage>
              <history>
                <date date-type="received">
                  <day>23</day>
                  <month>11</month>
                  <year>2017</year>
                </date>
                <date date-type="accepted">
                  <day>11</day>
                  <month>5</month>
                  <year>2018</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.</copyright-statement>
                <copyright-year>2018</copyright-year>
                <copyright-holder>American Academy of Neurology</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CC BY)</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri xlink:title="pdf" xlink:href="NEUROLOGY2017863324.pdf"/>
              <abstract>
                <sec>
                  <title>Objective</title>
                  <p>To determine the efficacy and safety of nonpharmacologic interventions for orthostatic hypotension (OH) secondary to aging.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p>A total of 150 orthostatic challenges were performed in 25 older people (age 60–92 years) to determine cardiovascular responses to bolus water drinking, compression stockings, abdominal compression, and physical countermaneuvers. Primary outcome was response rate as assessed by proportion of participants whose systolic blood pressure (SBP) drop improved by ≥10 mm Hg.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p>The response rate to bolus water drinking was 56% (95% confidence interval [CI] 36.7–74.2), with standing SBP increasing by 12 mm Hg (95% CI 4–20). Physical countermaneuvers were efficacious in 44% (95% CI 25.8–63.3) but had little effect on standing SBP (+7.5 mm Hg [95% CI −1 to 16]). Abdominal compression was efficacious in 52% (95% CI 32.9–70.7) and improved standing SBP (+10 mm Hg [95% CI 2–18]). Compression stockings were the least efficacious therapy (32% [95% CI 16.1–51.4]) and had little effect on standing SBP (+6 mm Hg [95% CI −1, 13]). No intervention improved symptoms during standing. There were no adverse events.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p>Bolus water drinking should become the standard first-line nonpharmacologic intervention, whereas compression stockings should be disregarded in this population.</p>
                </sec>
                <sec>
                  <title>Classification of evidence</title>
                  <p>This study provides Class III evidence that for older people with OH, bolus water drinking is superior to other nonpharmacologic interventions in decreasing SBP drop.</p>
                </sec>
              </abstract>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>OPEN-ACCESS</meta-name>
                  <meta-value>TRUE</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>STATUS</meta-name>
                  <meta-value>ONLINE-ONLY</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <p>Orthostatic hypotension (OH) is a disabling condition, resulting from a sustained reduction in blood pressure (BP; ≥20 mm Hg systolic or ≥10 mm Hg diastolic) within 3 minutes of standing.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> Aging is one of the most common causes of neurogenic OH, affecting 7% to 30% of community-dwelling older people.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Clinical guidelines recommend nonpharmacologic therapy as first-line treatment in OH, but older people are typically excluded from research, creating a great deal of clinical uncertainty.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> Because the older population is expanding rapidly, we can expect a growing demand for evidence in this area.</p>
            <sec sec-type="methods" id="s1">
              <title>Methods</title>
              <sec id="s1-1">
                <title>Population</title>
                <p>All participants were &gt;60 years of age and had OH according to international criteria.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> Dysautonomia was confirmed on autonomic function testing and was judged to be secondary to aging (in the absence of other identifiable causes). Exclusions were dysphagia, fluid restriction, and inability to wear compression garments. Participants were recruited via the UK Clinical Trials Gateway and a Falls and Syncope Service in Northeast England.</p>
              </sec>
              <sec id="s1-2">
                <title>Setting</title>
                <p>Procedures occurred between 9:30 and 11:30 <sc>am</sc> in the Falls and Syncope Service. Participants refrained from caffeine and nicotine and ate a light breakfast only before attending. Medications were withheld for ≥12 hours before attending.</p>
              </sec>
              <sec id="s1-3">
                <title>Interventions</title>
                <p>Selection of nonpharmacologic interventions was based on a recent systematic review and recommendations of the European Federation of Neurological Sciences<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup>: bolus water drinking (480 mL tap water consumed within 5 minutes), physical countermaneuvers (standing cross-legged<sup><xref rid="R5" ref-type="bibr">5</xref></sup>), compression stockings (to upper thigh [23–32 mm Hg]), and abdominal compression (elastic belt).</p>
              </sec>
              <sec id="s1-4">
                <title>Procedure</title>
                <sec id="s1-4-1">
                  <title>Visit 1</title>
                  <p>To establish a control BP profile, participants rested supine for 10 minutes while undergoing continuous cardiovascular monitoring (Task Force Monitor, CNSystems, Graz, Austria) before standing upright for 3 minutes and noting symptoms. Participants then ingested the water. After 20 minutes, the orthostatic challenge was repeated.<sup><xref rid="R6" ref-type="bibr">6</xref></sup></p>
                  <p>To estimate levels of frailty, dominant handgrip strength was quantified with a hydraulic dynamometer (Jamar, Sammons Preston Inc., Bolingbrook, IL). The Charlson Comorbidity Index score was calculated to illustrate the cohort's comorbidity.</p>
                </sec>
                <sec id="s1-4-2">
                  <title>Visit 2</title>
                  <p>A control orthostatic BP profile was established with the aforementioned methods. Participants were randomized to the order in which the interventions were administered by selecting a sealed opaque envelope. An orthostatic challenge (supine and standing BP) was repeated for each intervention with a 20-minute washout period between the challenges.</p>
                </sec>
              </sec>
              <sec id="s1-5">
                <title>Outcomes</title>
                <p>The primary outcome was response rate to each intervention (proportion of participants whose systolic BP drop improved ≥10 mm Hg). The secondary outcomes were nadir standing systolic BP, BP drop, adverse events, and symptoms (Orthostatic Hypotension Questionnaire Symptom Assessment<sup><xref rid="R7" ref-type="bibr">7</xref></sup>: participants rate the severity of 6 symptoms [dizziness/lightheadedness, vision, weakness, fatigue, trouble concentrating, head/neck discomfort] from 0 to 10, from which an average score is derived [maximum severity 10]; the Daily Activity Scale was not evaluated because this is a longer-term measure of symptom impact).</p>
              </sec>
              <sec id="s1-6">
                <title>Analysis</title>
                <p>An exact, single-stage, phase 2 study design was used.<sup><xref rid="R8" ref-type="bibr">8</xref></sup> The study had 80% power to demonstrate a 30% response rate and a 95% chance of rejecting interventions with response rates ≤10%.</p>
                <p>The mean and SD are displayed for normally distributed data; median (range) is used for nonparametric data. Response rates with 95% confidence intervals (CIs) were calculated with the use of exact binomial methods. The paired <italic toggle="yes">t</italic> test and Wilcoxon signed-rank test were used for statistical comparison of secondary outcomes using 2-sided <italic toggle="yes">p</italic> values.</p>
              </sec>
              <sec id="s1-7">
                <title>Standard protocol approvals, registrations, and patient consents</title>
                <p>This study was approved by the UK National Research Ethics Service (Newcastle and North Tyneside 2). All participants gave written informed consent. The study was registered prospectively with the UK Clinical Trials Gateway on September 12, 2015 (ISRCTN15084870).</p>
              </sec>
              <sec id="s1-8">
                <title>Classification of evidence</title>
                <p>The primary objective was to define the response rate to each therapy. This study provides Class III evidence that for older people with OH, bolus water drinking is superior to other nonpharmacologic interventions in decreasing systolic BP drop.</p>
              </sec>
              <sec sec-type="data-availability" id="s1-9">
                <title>Data availability</title>
                <p>Anonymized data generated during the current study are available from the corresponding author on reasonable request from individuals affiliated with research or health care institutions.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="s2">
              <title>Results</title>
              <p>Twenty-five participants were recruited between January and November 2016 (<xref rid="F1" ref-type="fig">figure 1</xref>). Demographic and baseline data are displayed in the <xref rid="T1" ref-type="table">table</xref>. The median grip strength is slightly lower than UK age-adjusted population norms, suggesting a degree of frailty.<sup><xref rid="R9" ref-type="bibr">9</xref></sup> The effect of each intervention on standing systolic BP is shown in <xref rid="F2" ref-type="fig">figure 2</xref>. There were no adverse events. No intervention had a significant impact on the specific symptom of dizziness/lightheadedness (data available from Dryad, table 1, <ext-link xlink:href="https://doi.org/10.5061/dryad.h37j22d" ext-link-type="uri">doi.org/10.5061/dryad.h37j22d</ext-link>). Results for the Orthostatic Hypotension Questionnaire Symptom Assessment subscale are provided below.</p>
              <fig position="float" id="F1">
                <label>Figure 1</label>
                <caption>
                  <title>Summary of participant screening and enrollment</title>
                  <p>BP = blood pressure.</p>
                </caption>
                <graphic xlink:href="NEUROLOGY2017863324FF1" position="float"/>
              </fig>
              <table-wrap position="float" id="T1">
                <label>Table</label>
                <caption>
                  <p>Baseline characteristics</p>
                </caption>
                <graphic xlink:href="NEUROLOGY2017863324TT1" position="float"/>
              </table-wrap>
              <fig position="float" id="F2">
                <label>Figure 2</label>
                <caption>
                  <title>Change in standing systolic BP</title>
                  <p>Change in standing systolic blood pressure (BP) with each intervention compared to no intervention. Control refers to the difference between the baseline postural BP assessments on visits 1 and 2. CI = confidence interval; PCM = physical countermaneuver.</p>
                </caption>
                <graphic xlink:href="NEUROLOGY2017863324FF2" position="float"/>
              </fig>
              <sec id="s2-1">
                <title>Bolus water drinking</title>
                <p>The median volume of water consumed was 480 mL (248–480 mL). Fourteen participants responded to bolus water drinking (response rate 56%, 95% CI 37%–74%). Systolic BP drop was significantly lower after water (33 [19] mm Hg, <italic toggle="yes">p</italic> = 0.021). There was no effect on diastolic BP drop (15 [12] mm Hg, <italic toggle="yes">p</italic> = 0.103) or on symptoms (1 [0–8], <italic toggle="yes">p</italic> = 0.923).</p>
              </sec>
              <sec id="s2-2">
                <title>Physical countermaneuvers</title>
                <p>Eleven participants responded to physical countermaneuvers (response rate 44%, 95% CI 26%–63%). There was no effect on systolic BP drop (35 [24] mm Hg, <italic toggle="yes">p</italic> = 0.085) or on symptoms (2.2 [0–6.8], <italic toggle="yes">p</italic> = 0.117). However, diastolic BP drop improved significantly (13 [16] mm Hg, <italic toggle="yes">p</italic> = 0.047).</p>
              </sec>
              <sec id="s2-3">
                <title>Compression stockings</title>
                <p>Eight participants responded to compression stockings (response rate 32%, 95% CI 16%–51%, <italic toggle="yes">p</italic> = 0.002). There was no change in systolic or diastolic BP drop (40 [21] mm Hg, <italic toggle="yes">p</italic> = 0.642 and18 [13] mm Hg, <italic toggle="yes">p</italic> = 0.815, respectively) or in symptoms (0.8 [0–7], <italic toggle="yes">p</italic> = 0.818).</p>
              </sec>
              <sec id="s2-4">
                <title>Abdominal compression</title>
                <p>Thirteen participants responded to abdominal compression (response rate 52%, 95% CI 33%–71%, <italic toggle="yes">p</italic> &lt; 0.001). Systolic BP drop reduced significantly (32 [18] mm Hg, <italic toggle="yes">p</italic> = 0.007), but diastolic BP drop did not (15.3 [12] mm Hg, <italic toggle="yes">p</italic> = 0.192). There was no change in symptoms (1.3 [0–6.3], <italic toggle="yes">p</italic> = 0.447).</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="s3">
              <title>Discussion</title>
              <p>This study demonstrates that bolus water drinking is the most efficacious nondrug therapy for aging-associated OH. Abdominal compression and physical countermaneuvers also resulted in reasonable response rates but had variable effects on secondary cardiovascular outcomes. In contrast, full leg length compression resulted in relatively low response rates and had no effect on secondary outcomes. The absence of any effect on symptoms is likely explained by a lack of power to detect small changes in secondary outcomes. The median symptom score was much higher during physical countermaneuvers, possibly due to the cardiovascular effects of physical exertion such as vasodilation or possibly to a reduced standing balance.</p>
              <p>Because nonpharmaceutical interventions are recommended as first-line therapy and are preferred by older people, it is essential that we develop a robust evidence base for their use,<sup><xref rid="R4" ref-type="bibr">4</xref></sup> particularly in the context of the rapidly expanding older population.<sup><xref rid="R10" ref-type="bibr">10</xref></sup> Furthermore, there are special considerations that are relevant to older populations. Older people are more likely to have coexisting problems (e.g., urinary incontinence, limited mobility) that may limit the use of nondrug interventions. Compression garments may also be limited by the difficulties of applying and removing these single-handedly. If clinicians are to recommend therapies when barriers exist, it is important that the value of the intervention is known to aid patient education and ultimately adherence.</p>
              <p>This phase II study is relatively small, limiting its external validity. Further evaluation is needed to explore the efficacy of combined therapies and to establish long-term effectiveness. It is important to note that in each case, the control orthostatic BP was performed first, closer in time to any preceding meal. This could have exerted greater postprandial hypotensive effects on the control BP compared to the interventions, exaggerating the beneficial effects of the interventions.</p>
              <p>Bolus water drinking should become the standard first-line nonpharmacologic intervention, whereas compression stockings should be disregarded in this population.</p>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn fn-type="supplementary-material">
                <p>Class of Evidence: <ext-link xlink:href="http://NPub.org/coe" ext-link-type="uri">NPub.org/coe</ext-link></p>
              </fn>
            </fn-group>
            <sec sec-type="contributions">
              <title>Author contributions</title>
              <p content-type="contributions">J.L.N.: study concept, data interpretation, manuscript preparation. J.F.: study concept and design, data collection, analysis and interpretation, statistical analysis, and manuscript preparation.</p>
            </sec>
            <sec sec-type="funding">
              <title>Study funding</title>
              <p content-type="funding">No targeted funding reported.</p>
            </sec>
            <sec sec-type="coi-statement">
              <title>Disclosure</title>
              <p>Dr. Newton: has received research funding from UK National Institute for Health Research Efficacy and Mechanism Evaluation, Arthritis Research UK, ME Research UK and Action for ME. Dr. Frith: This report is independent research arising from a Clinician Scientist Award (CS-2014-14-002) supported by the UK National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the UK NHS, the National Institute for Health Research, or the Department of Health. Dr. Frith has also received research funding from The Dowager Countess Eleanor Peel Trust. Go to <ext-link xlink:href="http://n.neurology.org/lookup/doi/10.1212/WNL.0000000000005994" ext-link-type="uri">Neurology.org/N</ext-link> for full disclosures.</p>
            </sec>
            <glossary>
              <title>Glossary</title>
              <def-list>
                <def-item>
                  <term id="G1">BP</term>
                  <def>
                    <p>blood pressure</p>
                  </def>
                </def-item>
                <def-item>
                  <term id="G2">CI</term>
                  <def>
                    <p>confidence interval</p>
                  </def>
                </def-item>
                <def-item>
                  <term id="G3">OH</term>
                  <def>
                    <p>orthostatic hypotension</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <ref-list>
              <title>References</title>
              <ref id="R1">
                <label>1.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Freeman</surname><given-names>R</given-names></string-name>, <string-name><surname>Wieling</surname><given-names>W</given-names></string-name>, <string-name><surname>Axelrod</surname><given-names>FB</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome</article-title>. <source>Clin Auton Res</source><year>2011</year>;<volume>21</volume>:<fpage>69</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">21431947</pub-id></mixed-citation>
              </ref>
              <ref id="R2">
                <label>2.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Low</surname><given-names>PA</given-names></string-name></person-group>. <article-title>Prevalence of orthostatic hypotension</article-title>. <source>Clin Auton Res</source><year>2008</year>;<volume>18</volume>:<fpage>8</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">18368301</pub-id></mixed-citation>
              </ref>
              <ref id="R3">
                <label>3.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mills</surname><given-names>PB</given-names></string-name>, <string-name><surname>Fung</surname><given-names>CK</given-names></string-name>, <string-name><surname>Travlos</surname><given-names>A</given-names></string-name>, <string-name><surname>Krassioukov</surname><given-names>A</given-names></string-name></person-group>. <article-title>Nonpharmacologic management of orthostatic hypotension: a systematic review</article-title>. <source>Arch Phys Med Rehabil</source><year>2015</year>;<volume>96</volume>:<fpage>366</fpage>–<lpage>375 e366</lpage>.<pub-id pub-id-type="pmid">25449193</pub-id></mixed-citation>
              </ref>
              <ref id="R4">
                <label>4.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lahrmann</surname><given-names>H</given-names></string-name>, <string-name><surname>Cortelli</surname><given-names>P</given-names></string-name>, <string-name><surname>Hilz</surname><given-names>M</given-names></string-name>, <string-name><surname>Mathias</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Struhal</surname><given-names>W</given-names></string-name>, <string-name><surname>Tassinari</surname><given-names>M</given-names></string-name></person-group>. <article-title>EFNS guidelines on the diagnosis and management of orthostatic hypotension</article-title>. <source>Eur J Neurol</source><year>2006</year>;<volume>13</volume>:<fpage>930</fpage>–<lpage>936</lpage>.<pub-id pub-id-type="pmid">16930356</pub-id></mixed-citation>
              </ref>
              <ref id="R5">
                <label>5.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wieling</surname><given-names>W</given-names></string-name>, <string-name><surname>van Dijk</surname><given-names>N</given-names></string-name>, <string-name><surname>Thijs</surname><given-names>RD</given-names></string-name>, <string-name><surname>de Lange</surname><given-names>FJ</given-names></string-name>, <string-name><surname>Krediet</surname><given-names>CT</given-names></string-name>, <string-name><surname>Halliwill</surname><given-names>JR</given-names></string-name></person-group>. <article-title>Physical countermeasures to increase orthostatic tolerance</article-title>. <source>J Intern Med</source><year>2015</year>;<volume>277</volume>:<fpage>69</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="pmid">24697914</pub-id></mixed-citation>
              </ref>
              <ref id="R6">
                <label>6.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jordan</surname><given-names>J</given-names></string-name>, <string-name><surname>Shannon</surname><given-names>JR</given-names></string-name>, <string-name><surname>Black</surname><given-names>BK</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The pressor response to water drinking in humans: a sympathetic reflex?</article-title><source>Circulation</source><year>2000</year>;<volume>101</volume>:<fpage>504</fpage>–<lpage>509</lpage>.<pub-id pub-id-type="pmid">10662747</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <label>7.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kaufmann</surname><given-names>H</given-names></string-name>, <string-name><surname>Malamut</surname><given-names>R</given-names></string-name>, <string-name><surname>Norcliffe-Kaufmann</surname><given-names>L</given-names></string-name>, <string-name><surname>Rosa</surname><given-names>K</given-names></string-name>, <string-name><surname>Freeman</surname><given-names>R</given-names></string-name></person-group>. <article-title>The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale</article-title>. <source>Clin Auton Res</source><year>2012</year>;<volume>22</volume>:<fpage>79</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">22045363</pub-id></mixed-citation>
              </ref>
              <ref id="R8">
                <label>8.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>A'Hern</surname><given-names>RP</given-names></string-name></person-group>. <article-title>Sample size tables for exact single-stage phase II designs</article-title>. <source>Stat Med</source><year>2001</year>;<volume>20</volume>:<fpage>859</fpage>–<lpage>866</lpage>.<pub-id pub-id-type="pmid">11252008</pub-id></mixed-citation>
              </ref>
              <ref id="R9">
                <label>9.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dodds</surname><given-names>RM</given-names></string-name>, <string-name><surname>Syddall</surname><given-names>HE</given-names></string-name>, <string-name><surname>Cooper</surname><given-names>R</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Grip strength across the life course: normative data from twelve British studies</article-title>. <source>PLoS One</source><year>2014</year>;<volume>9</volume>:<fpage>e113637</fpage>.<pub-id pub-id-type="pmid">25474696</pub-id></mixed-citation>
              </ref>
              <ref id="R10">
                <label>10.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Frith</surname><given-names>J</given-names></string-name>, <string-name><surname>Elliott</surname><given-names>CS</given-names></string-name>, <string-name><surname>Bashir</surname><given-names>A</given-names></string-name>, <string-name><surname>Newton</surname><given-names>J</given-names></string-name></person-group>. <article-title>Public and patient research priorities for orthostatic hypotension</article-title>. <source>Age Ageing</source><year>2014</year>;<volume>43</volume>:<fpage>865</fpage>–<lpage>868</lpage>.<pub-id pub-id-type="pmid">25146411</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
